From: Inflammatory markers and physical frailty: towards clinical application
Studies | Design | Population | Inflammation parameter of frailty using different measurements | ||||||
---|---|---|---|---|---|---|---|---|---|
FP | FI | Function | CGA | FRAIL | SF, EFS, GFI, G8, and TFI | SPPB | |||
Hubbard 2009 | Cross-sectional | > 75y, n = 110 | IL-6, TNF-α, CRP, Albumin | IL-6, TNF-α, CRP, Albumin | IL-6, TNF-α, CRP, Albumin | N/S | N/S | N/S | N/S |
Ronning 2010 | Cross-sectional | > 70y, n = 137 | IL-6, TNF-α, CRP, D-dimer | N/S | N/S | IL-6, TNF-α, CRP, D-dimer | N/S | N/S | N/S |
Collerton 2012 | Cross-sectional | > 85y, n = 845 | IL-6, TNF-α, CRP, Albumin | IL-6, TNF-α, CRP, albumin, WBC, neutrophils | N/S | N/S | N/S | N/S | N/S |
Chao 2015 | Cross-sectional | ~ 67.3y, n = 46 | N/S | N/S | N/S | N/S | Albumin | None | N/S |
Singer 2015 | Nested case-control | > 18y, n = 395 | IL-6, TNFR1, Leptin | N/S | N/S | N/S | N/S | N/S | TNFR1 |
Lu 2016 | Cross-sectional | > 55y, n = 76 | spg130, I-309, MCP-1, IL-6R, IL-2Ra | spg130, I-309, MCP-1, BCA-1, RANTES, Leptin | N/S | N/S | N/S | N/S | N/S |
Hsu 2019 | Longitudinal (3y) | > 75y, n = 901 | IL-6, IL-8; Factor consisting of IFN-γ, IL-4, IL-1β, IL-1Rα, G-CSF, IL-8, IL-6 and IL-7 | IL-6, IL-8 | N/S | N/S | N/S | N/S | N/S |
Welstead 2020 | Longitudinal (12y) | ~ 69.6y, n = 550 | - | CRP, fibrinogen | N/S | N/S | N/S | N/S | N/S |